Biogen | Dochód Netto

Cena Akcji
185.36
Dzienna Zmiana
-0.09 -0.05%
Miesięcznie
1.51%
Rocznie
30.20%
Q1 Prognozy TE
174.35




Dochód Netto Zmiana Data
AbbVie USD 1.82B 1.63B 2025-12
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
ALKERMES USD 82.76M 4.34M 2025-09
Amgen USD 1.33B 1.88B 2025-12
Bayer EUR -963M 764M 2025-09
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 3.05B 1.09B 2025-09
Incyte USD 424.17M 19.17M 2025-09
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
United Therapeutics USD 338.7M 29.2M 2025-09
Vertex Pharmaceuticals USD 1.08B 50M 2025-09


Biogen Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.